Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.3590
-0.0070 (-1.91%)
Sep 2, 2026, 5:29 PM CET
Nanologica AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 53.8 | 21.13 | 14.54 | 4.67 | 5.83 | 14.72 |
Other Revenue | 82.37 | - | - | - | 0.01 | 0.02 |
| 136.17 | 21.13 | 14.54 | 4.67 | 5.83 | 14.75 | |
Revenue Growth | 570.61% | 45.32% | 211.17% | -19.92% | -60.43% | -19.58% |
Cost of Revenue | 16.41 | 16.83 | 10.25 | 4.75 | 2.59 | 9.8 |
Gross Profit | 119.76 | 4.3 | 4.29 | -0.08 | 3.24 | 4.94 |
Selling, General & Admin | 77.65 | 41.26 | 38.68 | 40.5 | 41.52 | 33.81 |
Other Operating Expenses | 1.77 | -2.46 | 8.41 | 9.59 | - | -0.3 |
Operating Expenses | 97.19 | 51.24 | 61.21 | 69.46 | 53.38 | 43.97 |
Operating Income | 22.58 | -46.94 | -56.92 | -69.54 | -50.14 | -39.03 |
Interest Expense | -3.48 | -3.98 | -6.3 | -5.71 | -5.01 | -3.23 |
Interest & Investment Income | 0.2 | 0.2 | 0.35 | 0.46 | 0.04 | - |
Currency Exchange Gain (Loss) | -0.56 | -0.56 | -1.3 | -0.11 | -0.27 | -0.5 |
Other Non Operating Income (Expenses) | 0.06 | -0 | - | - | 0 | 0 |
EBT Excluding Unusual Items | 18.8 | -51.28 | -64.17 | -74.9 | -55.37 | -42.76 |
Gain (Loss) on Sale of Investments | - | - | - | - | 0.63 | -0.9 |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | - | -0.26 | -0.49 | -1.17 |
Asset Writedown | - | - | -1.43 | - | - | - |
Pretax Income | 18.79 | -51.29 | -65.59 | -75.16 | -55.23 | -44.83 |
Income Tax Expense | - | - | 0.04 | - | - | - |
Net Income | 18.79 | -51.29 | -65.63 | -75.16 | -55.23 | -44.83 |
Net Income to Common | 18.79 | -51.29 | -65.63 | -75.16 | -55.23 | -44.83 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 195 | 88 | 50 | 36 | 30 | 28 |
Shares Outstanding (Diluted) | 195 | 88 | 50 | 36 | 30 | 28 |
Shares Change | 181.26% | 78.40% | 37.04% | 20.39% | 7.25% | 17.19% |
EPS (Basic) | 0.10 | -0.58 | -1.32 | -2.08 | -1.84 | -1.60 |
EPS (Diluted) | 0.10 | -0.58 | -1.32 | -2.08 | -1.84 | -1.60 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -58.38 | -40.91 | -81 | -37.6 | -46.82 | -47.3 |
Free Cash Flow Per Share | -0.30 | -0.46 | -1.64 | -1.04 | -1.56 | -1.69 |
Gross Margin | 87.95% | 20.33% | 29.53% | -1.63% | 55.57% | 33.52% |
Operating Margin | 16.58% | -222.19% | -391.53% | -1488.40% | -859.39% | -264.71% |
Profit Margin | 13.80% | -242.76% | -451.43% | -1608.67% | -946.71% | -304.03% |
Free Cash Flow Margin | -42.88% | -193.66% | -557.13% | -804.88% | -802.50% | -320.79% |
EBITDA | 27.8 | -46.11 | -55.72 | -68.68 | -48.95 | -37.83 |
EBITDA Margin | 20.41% | -218.24% | - | - | - | -256.53% |
D&A For EBITDA | 5.22 | 0.84 | 1.2 | 0.86 | 1.19 | 1.21 |
EBIT | 22.58 | -46.94 | -56.92 | -69.54 | -50.14 | -39.03 |
EBIT Margin | 16.58% | -222.19% | - | - | - | -264.71% |